Widely used:Recently Viewed
Clear All
₹103 Cr
16.18
2.54
45.69
0.29
17.4 %
--
0 %
53.91
9
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Godavari Drugs
| 56.84 | 39.85 | 42.02 | 42.32 | 26.16 | 52.76 | 24.71 |
|
BSE Healthcare
| 39.03 | 6.55 | 18.12 | 53.85 | 18.21 | 27.77 | 12.14 |
|
BSE Small Cap
| 33.55 | 5.82 | 10.25 | 51.57 | 26.72 | 34.61 | 17.75 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Godavari Drugs
| -5.10 | 51.48 | 62.53 | 120.13 | -31.25 | -43.85 | -1.09 |
|
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
No Review & Analysis are available.
Our rating system has guided millions of investors in the past 20 years.
No Review & Analysis are available.
₹103.13 Cr
₹153.50 Cr
₹6.37 Cr
₹2.62 Cr
₹57.77 Cr
53.16%
Moderate
₹82.10 - 155.00
₹10.00
75,30,500
BSE: 530317
Secunderabad, Telangana
www.godavaridrugs.com
Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid,... enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services. It serves the life science industry. The company was incorporated in 1987 and is based in Secunderabad, India. Read more
The total asset value of Godavari Drugs Ltd stood at ₹ 135 Cr as on 30-Jun-24
The share price of Godavari Drugs Ltd is ₹141.25 (BSE) as of 19-Sep-2024 09:42 IST. Godavari Drugs Ltd has given a return of 26.16% in the last 3 years.
Godavari Drugs Ltd has a market capitalisation of ₹ 103 Cr as on 18-Sep-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Godavari Drugs Ltd is 2.54 times as on 18-Sep-2024, a 62% discount to its peers’ median range of 6.72 times.
The P/E ratio of Godavari Drugs Ltd is 16.18 times as on 18-Sep-2024, a 65% discount to its peers’ median range of 45.69 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Godavari Drugs Ltd and enter the required number of quantities and click on buy to purchase the shares of Godavari Drugs Ltd.
Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services. It serves the life science industry. The company was incorporated in 1987 and is based in Secunderabad, India.
The prominent promoters of Godavari Drugs Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
SUSHMA KAKANI |
15.34%
|
|
KAMALA JAJU |
12.08%
|
|
MOHIT JAJU |
7.1%
|
|
GHANSHYAM JAJU |
4.65%
|
|
MUKUND KAKANI |
4.65%
|
The chairman of the company is Ghanshyam Jaju, and the managing director is Mukund Kakani.
The promoters of Godavari Drugs Ltd have pledged 0.66% of the total equity as on Jun-24.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
12,447
|
|
|
9,717
|
|
|
8,644
|
|
|
8,635
|
| Godavari Drugs Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
17.4
|
|
Operating margin(%)
|
7.96
|
|
Net Margin(%)
|
4.13
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Godavari Drugs Ltd was ₹6 Cr.
₹4.30
